Moderna to supply 13 million COVID vaccine doses to Philippines
US biotechnology company Moderna Inc. announced a supply agreement with the Government of The Philippines to provide 13 million doses of COVID-19 Vaccine Moderna to the Philippines. Moderna is pioneering messenger RNA (mRNA) therapeutics and vaccines. Under the terms of this agreement, deliveries would begin in mid-2021. The COVID-19 Vaccine Moderna is not currently approved for use in the Philippines, and the Company will work with regulators to pursue necessary approvals prior to distribution.
Meanwhile the COVID-19 Vaccine Moderna has been granted temporary approval by Swissmedic, the Swiss Agency for Therapeutic Products, based upon the recommendation of the Human Medicines Expert Committee (HMEC), which authorizes the COVID-19 Vaccine Moderna for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus in individuals 18 years of age and older.
Reviewed by Editor
on
March 07, 2021
Rating:
Bahrain Herald was born during the height of COVID-19 pandemic with many print publications closing shop. We invested in human capital and made a smooth transition to remote work to facilitate our team of reporters to function freely. We have also benefitted immensely from Bahrain’s status as a regional leader in digital infrastructure, as well as one of the first nations to introduce a nationwide 5G network. Bahrain has one of the highest Internet penetration levels in the MENA region at 99% with a median age of 32.5 years. More than 89% of the 1.7 million people are urbanized. These major factors have contributed to a paradigm shift in media consumption habits and with easy access to smartphones, tablets, computers and free Wi-Fi - the growth of the digital media scene has been significant and this digital resilience is projected to grow stronger in the imminent future.
